| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/24/2004 | US20040121004 protecting the gastrointestinal tract from non-steroidal antiinflammatory drug therapy by administering a NSAID in combination with a buffer and a proton pump inhibitor in a single non-enterically coated dosage form |
| 06/24/2004 | US20040121003 blending the microparticles containing a drug with the excipient to form a powder blend; jet milling the blend to deagglomerate the microparticles which have agglomerated, while maintaining the size and morphology of indivisual microparticle |
| 06/24/2004 | US20040121001 Orally adminstrable opioid formulations having extended duration of effect |
| 06/24/2004 | US20040121000 Ingestible compositions containing an odoriferous oil |
| 06/24/2004 | US20040120999 Liposome containing remedy for vascular disease |
| 06/24/2004 | US20040120997 liposomes containing a sterol skeleton based compound wherein one or several amphoteric groups with an isoelectric point of between 4 and 9 are substituted on the 3rd position of the ring system |
| 06/24/2004 | US20040120996 administering as a transdermal patch, containing oxybutynin to a patient a duration about 24 to 96 hours to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from 0.5:1 to 5:1 to treat overactive bladder |
| 06/24/2004 | US20040120995 a non-woven medical absorbent and the pergolide is dissolved in an aqueous based solvent |
| 06/24/2004 | US20040120994 polymer matrix contains the sex hormone testosterone and a mixture of a penetration-enhancing substance selected from fatty alcohol esters and fatty acid esters, and at least one readily volatile penetration-enhancing agent |
| 06/24/2004 | US20040120991 comprising functional agents such as: hydration agent, breath masking agent, flavor masking agent, tartar reducing agent etc., differentiated by various patterns, glitters, swirls etc. |
| 06/24/2004 | US20040120990 Absorbent proteins and methods for using same |
| 06/24/2004 | US20040120989 Article for debridement and detoxification of wounds |
| 06/24/2004 | US20040120986 acidic beverages and oral healthcare compositions; use of calcium in such compositions to alleviate or prevent the tooth damage associated with the consumption of acid |
| 06/24/2004 | US20040120940 Placental alkaline phosphatase to control diabetes |
| 06/24/2004 | US20040120931 Compositions having an inner core and at least two surrounding layers |
| 06/24/2004 | US20040120917 Cosmetic or dermopharmaceutical composition comprising an enzyme which is insoluble in an aqueous medium, as well as its uses |
| 06/24/2004 | US20040120904 Delivery system for functional compounds |
| 06/24/2004 | US20040120896 Buccal aerosol sprays or capsules using polar and non-polar solvent which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect |
| 06/24/2004 | US20040120895 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 06/24/2004 | US20040119179 Method for making very fine particles consisting of a principle inserted in a host molecule |
| 06/24/2004 | US20040118738 Water-soluble container having at least two openings |
| 06/24/2004 | US20040118414 Surface modified viscoelastics for ocular surgery |
| 06/24/2004 | US20040118407 Device for artificial respiration |
| 06/24/2004 | US20040118007 Methods and apparatus for making particles using spray dryer and in-line jet mill |
| 06/24/2004 | DE10354940A1 Mittel zur buccodentalen Hygiene beim Menschen und in der Tierheilkunde mit Melatonin als aktivem Bestandteil Means for buccodentalen hygiene in humans and in animal medicine with melatonin as an active ingredient |
| 06/24/2004 | DE10256775A1 Preparation of film forming composition for transmucosal delivery of nicotine used for treating tobacco addiction, includes converting nicotine free base to its salt with acid and/or incorporation of nicotine as salt |
| 06/24/2004 | DE10256774A1 Medicament for transmucosal or transdermal drug administration, containing combination of monoterpene and polyol, e.g. menthol and propanediol, as resorption improvers |
| 06/24/2004 | DE10253773B3 Use of acesulfamic acid as acidulant, useful in foods, beverages, pharmaceuticals and cosmetics, provides lower pH than standard food acids at equal acidic taste |
| 06/24/2004 | CA2510623A1 Body cavity washer, device for washing body cavity and method of washing body cavity |
| 06/24/2004 | CA2509043A1 Method of preparing biologically active formulations |
| 06/24/2004 | CA2508722A1 Controlled-release of an active substance into a high fat environment |
| 06/24/2004 | CA2508441A1 Propofol-containing fat emulsions |
| 06/24/2004 | CA2508437A1 Ph triggered targeted controlled release systems |
| 06/24/2004 | CA2508166A1 Compositions and methods related to lipid:emodin formulations |
| 06/24/2004 | CA2508145A1 Thin film delivery systems for volatile decongestants |
| 06/24/2004 | CA2507042A1 Tablet comprising efletirizine and pseudoephedrine |
| 06/24/2004 | CA2505407A1 Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
| 06/23/2004 | EP1431347A1 Composition containing fine particles for supporting biologically active substance thereon or having the same supported thereon and method for preparing these |
| 06/23/2004 | EP1430947A1 Multicompartment microparticles with liquid crystalline cores |
| 06/23/2004 | EP1430917A1 Compositions and medical devices utilizing bioabsorbable polymeric waxes |
| 06/23/2004 | EP1430903A1 Use of proteasome inhibitors for the treatment of viral infections |
| 06/23/2004 | EP1430897A2 Opioid formulations having extended controlled release |
| 06/23/2004 | EP1430896A1 NICOTINE−CONTAINING FILM PREPARATION |
| 06/23/2004 | EP1430895A1 Novel substituted benzimidazole dosage forms and method of using same |
| 06/23/2004 | EP1430892A1 Aqueous ecabet sodium solution preparation |
| 06/23/2004 | EP1430891A1 Oil-acid-emulsion for the treatment of joint diseases and for the stimulation of blood-circulation |
| 06/23/2004 | EP1430889A1 Edible coating composition |
| 06/23/2004 | EP1430888A1 Press-coated molded article undergoing quick disintegration |
| 06/23/2004 | EP1430887A1 Powder for inhalation containing Tiotropium |
| 06/23/2004 | EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 06/23/2004 | EP1430117A2 Plasticized hydrophilic glasses for improved stabilization of biological agents |
| 06/23/2004 | EP1430098A1 Gel matrix consisting of polyacrylic acid and polyvinyl pyrrolidone |
| 06/23/2004 | EP1430067A2 Eukaryotic cells and method for preserving cells |
| 06/23/2004 | EP1430059A1 Pharmaceutically acceptable salts of 20(s)-camptothecins |
| 06/23/2004 | EP1429915A1 Systems, methods and apparatuses for manufacturing dosage forms |
| 06/23/2004 | EP1429914A1 Systems, method and apparatuses for manufacturing dosage forms |
| 06/23/2004 | EP1429829A2 Nitric oxide generation |
| 06/23/2004 | EP1429809A2 Immediate release tablet |
| 06/23/2004 | EP1429808A1 Solid composition containing bacillus-type non-pathogenic bacterial spores |
| 06/23/2004 | EP1429802A1 Delivery system for biological component |
| 06/23/2004 | EP1429791A2 Method and topical formulation for treating skin conditions associated with aging |
| 06/23/2004 | EP1429781A2 Composition comprising nanoparticulate spironolactone |
| 06/23/2004 | EP1429780A1 Method of treating middle ear infections |
| 06/23/2004 | EP1429774A2 Stent coated with a substained-release drug delivery |
| 06/23/2004 | EP1429770A1 New formulations and use thereof |
| 06/23/2004 | EP1429769A1 New formulations and use thereof |
| 06/23/2004 | EP1429768A1 Novel medicaments for inhalation |
| 06/23/2004 | EP1429749A2 Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
| 06/23/2004 | EP1429748A1 Solid compositions comprising ramipril |
| 06/23/2004 | EP1429747A1 Core formulation comprising pioglitazone hydrochloride and a biguanide |
| 06/23/2004 | EP1429746A2 Dosage forms having an inner core and outer shell |
| 06/23/2004 | EP1429745A2 Composite dosage forms having an inlaid portion |
| 06/23/2004 | EP1429744A1 Morphine polymer release system |
| 06/23/2004 | EP1429743A1 Dosage forms having an inner core and outer shell with different shapes |
| 06/23/2004 | EP1429742A2 Modified release dosage forms |
| 06/23/2004 | EP1429741A1 Process for coating solid particles |
| 06/23/2004 | EP1429740A1 Core formulation comprising troglitazone and a biguanide |
| 06/23/2004 | EP1429739A1 Polymer release system |
| 06/23/2004 | EP1429738A2 Modified release dosage forms |
| 06/23/2004 | EP1429737A1 Modified release dosage forms |
| 06/23/2004 | EP1429736A2 Organoleptically acceptable intraorally disintegrating compositions |
| 06/23/2004 | EP1429735A2 Method and device for producing granulates that comprise at least one pharmaceutical active substance |
| 06/23/2004 | EP1429734A1 Controlled release solid dispersions |
| 06/23/2004 | EP1429733A1 Preparation of microparticles |
| 06/23/2004 | EP1429732A1 A core formulation |
| 06/23/2004 | EP1429731A1 Nanoparticulate insulin formulations |
| 06/23/2004 | EP1429730A2 Opioid formulations having reduced potential for abuse |
| 06/23/2004 | EP1429729A1 Combination dosage form containing a cholesterol -lowering agent , an inhibitor of the renin-angiotensin, and aspirin |
| 06/23/2004 | EP1429728A1 Sustained release preparations |
| 06/23/2004 | EP1429727A1 Apoptosis-mimicking synthetic entities and use thereof in medical treatment |
| 06/23/2004 | EP1429726A2 A method for preparing liposome formulations with a predefined release profile |
| 06/23/2004 | EP1429725A1 Ophthalmic depot formulations for periocular or subconjunctival administration |
| 06/23/2004 | EP1429724A1 Dosage form containing a confectionery composition |
| 06/23/2004 | EP1429723A1 Treating effects of excessive reactive oxygen species |
| 06/23/2004 | EP1429722A1 Spraying method for producing powder formulations |
| 06/23/2004 | EP1429712A2 Method for treating bronchial constriction and bronchospasm |
| 06/23/2004 | EP1429711A1 Method for making an insert |
| 06/23/2004 | EP1429689A1 Rational drug therapy device and methods |
| 06/23/2004 | EP1429622A1 Pet food product and method of manufacture |
| 06/23/2004 | EP1429617A2 Methods for sterilizing preparations of digestive enzymes |